These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
411 related articles for article (PubMed ID: 28963773)
41. Kinetics of Helios(+) and Helios(-) T regulatory cell subsets in the circulation of healthy pregnant women. Kopřivová H; Hájková M; Koucký M; Malíčková K; Holáň V; Krulová M Scand J Immunol; 2019 Apr; 89(4):e12754. PubMed ID: 30729559 [TBL] [Abstract][Full Text] [Related]
42. Regulatory T cell (Treg) subsets return in patients with refractory lupus following stem cell transplantation, and TGF-beta-producing CD8+ Treg cells are associated with immunological remission of lupus. Zhang L; Bertucci AM; Ramsey-Goldman R; Burt RK; Datta SK J Immunol; 2009 Nov; 183(10):6346-58. PubMed ID: 19841178 [TBL] [Abstract][Full Text] [Related]
43. Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis. Bonelli M; Göschl L; Blüml S; Karonitsch T; Hirahara K; Ferner E; Steiner CW; Steiner G; Smolen JS; Scheinecker C Rheumatology (Oxford); 2016 Apr; 55(4):710-20. PubMed ID: 26672908 [TBL] [Abstract][Full Text] [Related]
44. PD-1 Kamada T; Togashi Y; Tay C; Ha D; Sasaki A; Nakamura Y; Sato E; Fukuoka S; Tada Y; Tanaka A; Morikawa H; Kawazoe A; Kinoshita T; Shitara K; Sakaguchi S; Nishikawa H Proc Natl Acad Sci U S A; 2019 May; 116(20):9999-10008. PubMed ID: 31028147 [TBL] [Abstract][Full Text] [Related]
45. Function of regulatory T-cells improved by dexamethasone in Graves' disease. Hu Y; Tian W; Zhang LL; Liu H; Yin GP; He BS; Mao XM Eur J Endocrinol; 2012 Apr; 166(4):641-6. PubMed ID: 22219499 [TBL] [Abstract][Full Text] [Related]
46. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells. Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171 [TBL] [Abstract][Full Text] [Related]
47. Treg-mediated acquired resistance to immune checkpoint inhibitors. Saleh R; Elkord E Cancer Lett; 2019 Aug; 457():168-179. PubMed ID: 31078738 [TBL] [Abstract][Full Text] [Related]
48. Intratumoral FoxP3 Syed Khaja AS; Toor SM; El Salhat H; Ali BR; Elkord E Front Immunol; 2017; 8():619. PubMed ID: 28603527 [TBL] [Abstract][Full Text] [Related]
49. Effect of PD-L1 testing on the cost-effectiveness and budget impact of pembrolizumab for advanced urothelial carcinoma of the bladder in the United States. Criss SD; Weaver DT; Sheehan DF; Lee RJ; Pandharipande PV; Kong CY Urol Oncol; 2019 Mar; 37(3):180.e11-180.e18. PubMed ID: 30528699 [TBL] [Abstract][Full Text] [Related]
50. Nonoverlapping roles of PD-1 and FoxP3 in maintaining immune tolerance in a novel autoimmune pancreatitis mouse model. Zhang B; Chikuma S; Hori S; Fagarasan S; Honjo T Proc Natl Acad Sci U S A; 2016 Jul; 113(30):8490-5. PubMed ID: 27410049 [TBL] [Abstract][Full Text] [Related]
51. PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells. Park HJ; Park JS; Jeong YH; Son J; Ban YH; Lee BH; Chen L; Chang J; Chung DH; Choi I; Ha SJ J Immunol; 2015 Jun; 194(12):5801-11. PubMed ID: 25934860 [TBL] [Abstract][Full Text] [Related]
53. PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells. Wang W; Lau R; Yu D; Zhu W; Korman A; Weber J Int Immunol; 2009 Sep; 21(9):1065-77. PubMed ID: 19651643 [TBL] [Abstract][Full Text] [Related]
54. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+ regulatory T-cell activity to suppress alloimmune responses. Kitazawa Y; Fujino M; Wang Q; Kimura H; Azuma M; Kubo M; Abe R; Li XK Transplantation; 2007 Mar; 83(6):774-82. PubMed ID: 17414712 [TBL] [Abstract][Full Text] [Related]
56. CTLA4-Ig modifies dendritic cells from mice with collagen-induced arthritis to increase the CD4+CD25+Foxp3+ regulatory T cell population. Ko HJ; Cho ML; Lee SY; Oh HJ; Heo YJ; Moon YM; Kang CM; Kwok SK; Ju JH; Park SH; Park KS; Kim HY J Autoimmun; 2010 Mar; 34(2):111-20. PubMed ID: 19665867 [TBL] [Abstract][Full Text] [Related]
57. Immune Checkpoints in Circulating and Tumor-Infiltrating CD4 Toor SM; Murshed K; Al-Dhaheri M; Khawar M; Abu Nada M; Elkord E Front Immunol; 2019; 10():2936. PubMed ID: 31921188 [TBL] [Abstract][Full Text] [Related]